AI-generated summary
The authors treated 32 patients with melasma using low-energy Q-switched Nd:YAG and alexandrite lasers and graded results by pigment reduction. They report that 65.6% were cured and 34.4% were remarkably improved, with better outcomes in lighter pigmentation and shorter disease history, and no hyperpigmentation or scarring observed.
- Participants
- 32
- Who or what was studied
- 32 patients with melasma
- Limits stated in the abstract
- The abstract does not describe a control group, and it reports only a single small case series.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.